The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products … [Read more...] about The 24 best medical device innovations of 2022
Boston Scientific
Boston Scientific acquires Obsidio and its gel embolic material
Boston Scientific (NYSE:BSX) today announced the acquisition of Obsidio and its blood vessel embolization material technology. The financial details of the deal were not disclosed. Obsidio develops gel embolic material (GEM) technology that is used for the embolization of blood vessels in the peripheral vasculature. It is a semi-solid, gel-link … [Read more...] about Boston Scientific acquires Obsidio and its gel embolic material
Design challenges to overcome when developing cardiac ablation devices
It’s about figuring out how and where to go with the cardiac ablation and then engineering the best catheter-based delivery device, according to a top Acutus Medical scientist. Cardiac ablation is when a physician intentionally destroys a small amount of tissue in the heart to treat and prevent heart rhythm problems. The procedure creates … [Read more...] about Design challenges to overcome when developing cardiac ablation devices
What is pulsed-field ablation? Here’s what you need to know
Top experts at Boston Scientific, Medtronic and Acutus Medical shared insights about pulsed-field ablation’s potential at DeviceTalks Boston. Pulsed-field ablation is a non-thermal method for cardiac ablation that has the potential to positively disrupt the way atrial fibrillation is treated. PFA’s roots go back to the dc ablation tech of the … [Read more...] about What is pulsed-field ablation? Here’s what you need to know
Boston Scientific wins FDA clearance for Embold fibered detached coil
Boston Scientific (NYSE:BSX) this week announced it received FDA 510(k) clearance for the Embold fibered detachable coil for use in the peripheral vasculature. Marlborough, Massachusetts-based Boston Scientific designed Embold for use in a number of embolization procedures that block one or more blood vessels to obstruct or reduce blood flow. … [Read more...] about Boston Scientific wins FDA clearance for Embold fibered detached coil
18 of the world’s most innovative medical technologies
Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that … [Read more...] about 18 of the world’s most innovative medical technologies
The top 10 catheter innovations of 2021
Last year was a big year for catheter innovation as medtech companies large and small received regulatory approvals for devices ranging from TAVR to single-use endoscopes. Catheter innovations weren't limited to just adults; Catheter-deployed devices for premature babies and toddlers were also approved and released. And catheter-based devices … [Read more...] about The top 10 catheter innovations of 2021
Boston Scientific recalls Hurricane RX biliary balloon dilation catheters
Boston Scientific has issued a warning letter recalling some of its Hurricane RX biliary balloon dilation catheters. Marlborough, Massachusetts-based Boston Scientific issued the recall because of complaints received for pinholes in the balloon. The balloon could rapidly lose pressure or fail to maintain pressure due to the issue. The recall … [Read more...] about Boston Scientific recalls Hurricane RX biliary balloon dilation catheters
Boston Scientific announces positive data for Eluvia stent
Boston Scientific this week announced positive data for its Eluvia drug-eluting vascular stent system. Data presented this week included one-year results from the company's Eminent trial, which showed superiority of the Eluvia stent compared to self-expanding bare metal stents (BMS) to treat patients with peripheral artery disease (PAD) and … [Read more...] about Boston Scientific announces positive data for Eluvia stent
Boston Scientific to acquire Devoro Medical and its Wolf thrombectomy platform
Boston Scientific today announced that it has entered an agreement to acquire Devoro Medical for more than $269 million. Marlborough, Massachusetts-based Boston Scientific has been a strategic investor in Devoro Medical since 2019, according to the company. It has an equity stake of approximately 16%. The transaction will consist of an upfront … [Read more...] about Boston Scientific to acquire Devoro Medical and its Wolf thrombectomy platform
